IBEX Limited (IBEX)
(Real Time Quote from BATS)
$19.85 USD
-0.14 (-0.70%)
Updated Sep 25, 2024 09:54 AM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for IBEX Limited falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | |
---|---|---|---|---|---|
Sales | 509 | 523 | 494 | 444 | 405 |
Cost Of Goods | 357 | 375 | 0 | 0 | 0 |
Gross Profit | 152 | 148 | 494 | 444 | 405 |
Selling & Adminstrative & Depr. & Amort Expenses | 113 | 108 | 464 | 429 | 385 |
Income After Depreciation & Amortization | 39 | 40 | 30 | 15 | 20 |
Non-Operating Income | 2 | 0 | 0 | 1 | 1 |
Interest Expense | 1 | 0 | 9 | 9 | 9 |
Pretax Income | 41 | 40 | 21 | 5 | 10 |
Income Taxes | 7 | 9 | -2 | 2 | 2 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 34 | 32 | 23 | 3 | 8 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 34 | 32 | 23 | 3 | 8 |
Depreciation Footnote | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 59 | 59 | 64 | 43 | 45 |
Depreciation & Amortization (Cash Flow) | 19 | 19 | 34 | 28 | 24 |
Income After Depreciation & Amortization | 39 | 40 | 30 | 15 | 20 |
Earnings Per Share Data | 6/30/24 | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 |
---|---|---|---|---|---|
Average Shares | 18.26 | 18.89 | 18.70 | 18.39 | 18.68 |
Diluted EPS Before Non-Recurring Items | 1.94 | 1.76 | 1.24 | 1.28 | 0.84 |
Diluted Net EPS (GAAP) | 1.84 | 1.67 | 1.23 | 0.15 | 0.00 |
Fiscal Year end for IBEX Limited falls in the month of June .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 124.53 | 126.80 | 132.63 | 124.61 | 124.26 |
Cost Of Goods | 85.37 | 87.08 | 95.88 | 88.20 | 374.99 |
Gross Profit | 39.16 | 39.71 | 36.75 | 36.41 | 124.26 |
SG&A, R&D, and Dept/Amort Expenses | 26.29 | 28.44 | 29.81 | 28.08 | -195.87 |
Income After SG&A, R&D, and Dept/Amort Expenses | 12.87 | 11.27 | 6.94 | 8.33 | 320.13 |
Non-Operating Income | 0.54 | 0.43 | 0.51 | 0.59 | 0.00 |
Interest Expense | 0.18 | 0.12 | 0.11 | 0.10 | -5.58 |
Pretax Income | 13.24 | 11.59 | 7.35 | 8.81 | 17.39 |
Income Taxes | 3.39 | 1.28 | 1.27 | 1.39 | 3.68 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 9.84 | 10.31 | 6.08 | 7.43 | 13.71 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 9.84 | 10.31 | 6.08 | 7.43 | 13.71 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 17.64 | 18.04 | 18.44 | 18.90 | 18.99 |
Diluted EPS Before Non-Recurring Items | 0.54 | 0.67 | 0.37 | 0.35 | 0.30 |
Diluted Net EPS (GAAP) | 0.55 | 0.57 | 0.33 | 0.39 | 0.73 |